Skip to content
Screener

Spyre Therapeutics, Inc. SYRE Q2 2026 earnings

Reported August 4, 2026 · After market close

EPS-$0.36Beat by $0.40
EPS estimate-$0.76

Next report

Nov 3, 2026 (in 2 months)
EPS estimate-$0.80

FAQ

When did Spyre Therapeutics, Inc. report Q2 2026 earnings?
Spyre Therapeutics, Inc. (SYRE) reported Q2 2026 earnings on August 4, 2026 after market close.
What were Spyre Therapeutics, Inc.'s Q2 2026 revenue and EPS?
Spyre Therapeutics, Inc. reported eps of $-0.36 for Q2 2026.
Did Spyre Therapeutics, Inc. beat estimates in Q2 2026?
EPS beat the consensus estimate of $-0.76 by $0.40.
How did Spyre Therapeutics, Inc.'s Q2 2026 results compare year-over-year?
Compared to the same quarter a year prior, eps grew 26.5% from $-0.49.
Where can I find Spyre Therapeutics, Inc.'s Q2 2026 SEC filings?
You can read the 8-K earnings release (0001636282-26-000098) and the 10-Q periodic report (0001636282-26-000096) directly on SEC EDGAR. The filing index links above go to sec.gov.